http://www.xconomy.com/boston/2009/03/09/stemgent-nails-down-14m-to-make-supplies-tools-for-stem-cell-researchers/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 http://www.xconomy.com/boston/2009/03/09/stemgent-nails-down-14m-to-make-supplies-tools-for-stem-cell-researchers/comment-page-1/#comment-73113 Hopkinson Mon, 03 Aug 2009 15:47:15 +0000 http://www.xconomy.com/?p=15443#comment-73113 Sheridan Snyder was the President and CEO of Upstate Group until the company was sold to Serologicals in 2004. Ratcliffe then became the President of the Upstate division of Serologicals for a short time. Sheridan Snyder was the President and CEO of Upstate Group until the company was sold to Serologicals in 2004. Ratcliffe then became the President of the Upstate division of Serologicals for a short time.

]]> http://www.xconomy.com/boston/2009/03/09/stemgent-nails-down-14m-to-make-supplies-tools-for-stem-cell-researchers/comment-page-1/#comment-50011 Recssion? Who’s Getting Financed This Week | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries Thu, 12 Mar 2009 01:50:26 +0000 http://www.xconomy.com/?p=15443#comment-50011 [...] -Finally, Stemgent raised $14M earlier this week from HealthCare Ventures and Morgenthaler Ventures. Stemgent plans to sell proprietary reagents, consumable materials and tools for stem cell researchers. [Xconomy] [...] [...] -Finally, Stemgent raised $14M earlier this week from HealthCare Ventures and Morgenthaler Ventures. Stemgent plans to sell proprietary reagents, consumable materials and tools for stem cell researchers. [Xconomy] [...]

]]> http://www.xconomy.com/boston/2009/03/09/stemgent-nails-down-14m-to-make-supplies-tools-for-stem-cell-researchers/comment-page-1/#comment-49719 News, Money and Drugs - Tuesday, March 10, 2009 | IguanaBio - A Daily Biotech and Pharma Tabloid - Gossip, News, Humor and Updates on the Latest Events in the Biotechnology and Pharmaceutical Industries Wed, 11 Mar 2009 02:35:23 +0000 http://www.xconomy.com/?p=15443#comment-49719 [...] -Obama + stem cells + tools = $14,000,000 for Stemgent. [Xconomy] [...] [...] -Obama + stem cells + tools = $14,000,000 for Stemgent. [Xconomy] [...]

]]> http://www.xconomy.com/boston/2009/03/09/stemgent-nails-down-14m-to-make-supplies-tools-for-stem-cell-researchers/comment-page-1/#comment-49647 Nodis Tue, 10 Mar 2009 20:06:49 +0000 http://www.xconomy.com/?p=15443#comment-49647 Stemgent hired an international employee by promising him working visa sponsorship. Two weeks before the visa application deadline, they fired him without giving him a warning, without giving him a specific reason. Is this just coincidence or Stemgent has totally taken advantage of international employees? Who cares about credibility? This company is all about money yet in the glorious name of "benefit world stem cell research". Stemgent hired an international employee by promising him working visa sponsorship. Two weeks before the visa application deadline, they fired him without giving him a warning, without giving him a specific reason. Is this just coincidence or Stemgent has totally taken advantage of international employees?
Who cares about credibility? This company is all about money yet in the glorious name of “benefit world stem cell research”.

]]> http://www.xconomy.com/boston/2009/03/09/stemgent-nails-down-14m-to-make-supplies-tools-for-stem-cell-researchers/comment-page-1/#comment-49548 MedCity morning read Tuesday, March 2 : MedCity News Tue, 10 Mar 2009 11:59:10 +0000 http://www.xconomy.com/?p=15443#comment-49548 [...] symbolic announcement, the same day Obama lifted the funding ban stem-cell tool maker Stegment received $14 million in venture [...] [...] symbolic announcement, the same day Obama lifted the funding ban stem-cell tool maker Stegment received $14 million in venture [...]

]]>